PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Beijing Med-Pharm Corporation (NASDAQ:BJGP) (“Beijing Med-Pharm” or the “Company”), one of China’s leading marketing and distribution pharmaceutical companies, on January 16, 2008 filed a Form 8-K/A which included unaudited pro forma financial information for the nine-month period ended September 30, 2007 and for the year ended December 31, 2006. Unaudited pro forma results reflect the pending completion of the acquisition of Hong Kong Fly International Health Care Limited (Hong Kong Health Care), a Hong Kong corporation that holds 51% of the equity interests of Sunstone Pharmaceutical Company Limited (Sunstone). On October 31, 2007, Beijing Med-Pharm acquired a 49% interest in Hong Kong Health Care and anticipates acquiring the remaining 51% in the first quarter of 2008.
